Correction to the Methods: Center Subfield Diameter Unit in the Aflibercept 8 mg PULSAR Analysis

October 1, 2026

Jama Ophthalmology

Objective:

Report an online correction to the Methods section of the Original Investigation “Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial.”

Approach:

Correction: The center subfield diameter unit was corrected from 1 cm to 1 mm.

Key Findings:

The correction was issued online on December 18, 2025, and the article subsequently appeared in the February 2026 issue.
In the Methods section, the center subfield diameter unit was corrected from 1 cm to 1 mm.

Interpretation:

The correction replaces 1 cm with 1 mm as the unit of measure for the center subfield diameter in the Methods section.

Limitations:

The provided context does not include the full article or additional details about the correction.

Sources:

Correction notice for “Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial.”

Correction to the Methods: Center Subfield Diameter Unit in the Aflibercept 8 mg PULSAR Analysis

Objective:

Approach:

Key Findings:

Interpretation:

Limitations:

Sources:

Original Source(s)

Error in Methods

Related Content

Repeat surgical interventions in non-Fuchs corneal dystrophies: insights from eight decades of histopathological and clinical data

FDA clears targeted cholangiocarcinoma therapy

Vitreous cyst may hide behind chronic floaters